Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Med Arch. 2009; 63(6): 332-334


Incidence of Secondary Vascular Complications After Stroke

Narcisa Vavra Hadziahmetovic, Zoran Hadziahmetovic.




Abstract

Stroke is a clinical syndrome characterized by the sudden occurrence of a permanent focal neurological deficit. The most common causes of death are transtentorial herniation, pneumonia, pulmonary embolism and heart disease. According to literature data, pulmonary embolism (PE) is responsible for 5% of deaths after stroke. AIM: The aim of this article is to determine the incidence of patients who had secondary vascular complications in the form of PE and deep venous thrombosis (DVT) after stroke and indicate the need for creating and promoting the algorithm for these complications in patients after stroke. MATERIAL AND METHODS: The study included 86 patients hospitalized at the Clinic of Physical Medicine and Rehabilitation in the period from October 2008 to October 2009 who have had rehabilitation as a continuation of the treatment immediately after the stroke. RESULTS: Hemorrhagic type was present in 13% of patients, and ischemic in 87%. As a secondary complication after stroke, five patients had pulmonary embolism. Neurological deficit in these patients was in the form of hemiplegia and were with ischemic type. Time from stroke until the appearance of symptoms of pulmonary embolism was in average 25.4 days. Suggested thrombi prophylaxis therapy (which they received before rehabilitation) in patients who have developed PE was Aspirin Protect, while no patient had recommended low molecular heparin. Physical therapy was performed for all patients, and mechanical methods of prophylaxis were used. CONCLUSION: Different attitudes about prophylaxis effects for these patients should be regulated by a unique algorithm that would reduce the possibility of discrepancy in therapeutic sense. That is why for patients with acute stroke and limited mobility it is recommended to use heparin or low molecular heparin (LMH) in preventive doses, if there are no contraindications for anticoagulants, with physical therapy and mechanical methods of prophylaxis.

Key words: stroke, pulmonary embolism, prevention






Full-text options


Share this Article



Online Article Submission
• ejmanager.com
• ojshosting.net







Do you want to use OJS for your journal ?
work with an experienced partner
www.OJSHosting.net

eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.